These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26274882)

  • 21. Emerging options for treating hepatitis C infection.
    Fantasia HC
    Nurs Womens Health; 2015; 19(2):183-7. PubMed ID: 25900589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. China rejects patent on hepatitis C drug sofosbuvir.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3429. PubMed ID: 26105994
    [No Abstract]   [Full Text] [Related]  

  • 23. Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.
    Aghemo A; Donato MF
    Gastroenterology; 2015 Jan; 148(1):13-6. PubMed ID: 25451651
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeted drugs to tackle hepatitis C.
    Mole B
    Nature; 2013 May; 497(7447):18-9. PubMed ID: 23636373
    [No Abstract]   [Full Text] [Related]  

  • 25. US health insurers say Gilead hepatitis C drug too costly.
    Clin Infect Dis; 2014 Jul; 59(2):i-ii. PubMed ID: 25105185
    [No Abstract]   [Full Text] [Related]  

  • 26. Sofosbuvir: first global approval.
    Keating GM; Vaidya A
    Drugs; 2014 Feb; 74(2):273-82. PubMed ID: 24442794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the treatment of hepatitis C.
    Dhingra A; Kapoor S; Alqahtani SA
    Discov Med; 2014 Oct; 18(99):203-8. PubMed ID: 25336034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sofosbuvir (Sovaldi) for chronic hepatitis C.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):5-6. PubMed ID: 24457562
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV-hepatitis C co-infection.
    Hayward P
    Lancet Infect Dis; 2015 Apr; 15(4):382. PubMed ID: 25809897
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C: Treatment triumphs.
    Rice CM; Saeed M
    Nature; 2014 Jun; 510(7503):43-4. PubMed ID: 24899301
    [No Abstract]   [Full Text] [Related]  

  • 31. Daclatasvir for the treatment of hepatitis C virus infection.
    Adler H; Lambert JS
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):725-38. PubMed ID: 24882552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transplant recipients with hepatitis C virus experienced 100% sustained virologic response at 12 weeks when treated with sofosbuvir-ledipasvir.
    Sise ME
    Hepatology; 2017 Oct; 66(4):1335-1337. PubMed ID: 28650558
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C.
    Cuenca-Lopez F; Rivero A; Rivero-Juárez A
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):105-112. PubMed ID: 27797596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sovaldi makes blockbuster history, ignites drug pricing unrest.
    Senior M
    Nat Biotechnol; 2014 Jun; 32(6):501-2. PubMed ID: 24911474
    [No Abstract]   [Full Text] [Related]  

  • 35. Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
    Sultanik P; Klotz C; Brault P; Pol S; Mallet V
    Blood; 2015 Apr; 125(15):2446-7. PubMed ID: 25858892
    [No Abstract]   [Full Text] [Related]  

  • 36. WHO issues guidelines on HCV amid drug cost controversy.
    Slomski A
    JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
    [No Abstract]   [Full Text] [Related]  

  • 37. The rapid evolution of treatment strategies for hepatitis C.
    Muir AJ
    Am J Gastroenterol; 2014 May; 109(5):628-35; quiz 636. PubMed ID: 24732866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938.
    Guedj J; Pang PS; Denning J; Rodriguez-Torres M; Lawitz E; Symonds W; Perelson AS
    Antivir Ther; 2014; 19(2):211-20. PubMed ID: 24464551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: patients' preferences and health utility assessment in those with HCV treated with sofosbuvir - stating the obvious?
    Lim SG; Gandhi M; Chan E
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1115. PubMed ID: 25280256
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C.
    Kumar S; Jacobson IM
    J Hepatol; 2014 Nov; 61(1 Suppl):S91-7. PubMed ID: 25443349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.